SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $450,000 | +147.3% | 70,085 | +32.2% | 0.00% | +200.0% |
| Q2 2022 | $182,000 | -85.5% | 53,006 | -69.9% | 0.00% | -83.3% |
| Q1 2022 | $1,254,000 | -30.9% | 176,075 | -19.2% | 0.01% | -33.3% |
| Q4 2021 | $1,816,000 | +443.7% | 217,968 | +354.3% | 0.01% | +350.0% |
| Q3 2021 | $334,000 | -55.8% | 47,981 | +51.6% | 0.00% | -50.0% |
| Q2 2021 | $755,000 | +545.3% | 31,657 | +85.1% | 0.00% | +300.0% |
| Q1 2019 | $117,000 | +56.0% | 17,100 | +3.6% | 0.00% | 0.0% |
| Q4 2018 | $75,000 | -38.0% | 16,500 | +3.1% | 0.00% | 0.0% |
| Q3 2018 | $121,000 | +3.4% | 16,000 | +17.6% | 0.00% | 0.0% |
| Q2 2018 | $117,000 | -72.6% | 13,600 | -64.1% | 0.00% | -66.7% |
| Q1 2017 | $427,000 | +186.6% | 37,850 | +151.1% | 0.00% | +200.0% |
| Q4 2016 | $149,000 | – | 15,075 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |